甲状腺がん治療の世界市場（～2026年）

• 英文タイトル：Global Thyroid Cancer Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04851
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は甲状腺がん治療のグローバル市場について調査・分析したレポートです。種類別（手術、ヨウ素療法、体外照射療法、サイロキシン治療、化学療法、薬物）市場規模、用途別（病院、腫瘍学センター、病院薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別甲状腺がん治療の競争状況、市場シェア
・世界の甲状腺がん治療市場：種類別市場規模 2015年-2020年（手術、ヨウ素療法、体外照射療法、サイロキシン治療、化学療法、薬物）
・世界の甲状腺がん治療市場：種類別市場規模予測 2021年-2026年（手術、ヨウ素療法、体外照射療法、サイロキシン治療、化学療法、薬物）
・世界の甲状腺がん治療市場：用途別市場規模 2015年-2020年（病院、腫瘍学センター、病院薬局、小売薬局）
・世界の甲状腺がん治療市場：用途別市場規模予測 2021年-2026年（病院、腫瘍学センター、病院薬局、小売薬局）
・北米の甲状腺がん治療市場分析：米国、カナダ
・ヨーロッパの甲状腺がん治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの甲状腺がん治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の甲状腺がん治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの甲状腺がん治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Baxter、Mylan、Alara、Bristol Myers、Abbott、Teva、App pharmaceuticals、Jerome Stevens
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Thyroid Cancer Treatment Market
The global Thyroid Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Thyroid Cancer Treatment Scope and Market Size
Thyroid Cancer Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Thyroid Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Baxter
Mylan
Alara
Bristol Myers
Abbott
Teva
App pharmaceuticals
Jerome Stevens

Market segment by Type, the product can be split into
Surgery
Iodine Therapy
External Radiotherapy
Thyroxin Treatment
Chemotherapy
Drugs
Market segment by Application, split into
Hospitals
Oncology centers
Hospital Pharmacies
Retail Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Thyroid Cancer Treatment Revenue
1.4 Market by Type
1.4.1 Global Thyroid Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Iodine Therapy
1.4.4 External Radiotherapy
1.4.5 Thyroxin Treatment
1.4.6 Chemotherapy
1.4.7 Drugs
1.5 Market by Application
1.5.1 Global Thyroid Cancer Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Oncology centers
1.5.4 Hospital Pharmacies
1.5.5 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Thyroid Cancer Treatment Market Perspective (2015-2026)
2.2 Global Thyroid Cancer Treatment Growth Trends by Regions
2.2.1 Thyroid Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Thyroid Cancer Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Thyroid Cancer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Thyroid Cancer Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Thyroid Cancer Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Thyroid Cancer Treatment Players by Market Size
3.1.1 Global Top Thyroid Cancer Treatment Players by Revenue (2015-2020)
3.1.2 Global Thyroid Cancer Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Thyroid Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Thyroid Cancer Treatment Market Concentration Ratio
3.2.1 Global Thyroid Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Thyroid Cancer Treatment Revenue in 2019
3.3 Thyroid Cancer Treatment Key Players Head office and Area Served
3.4 Key Players Thyroid Cancer Treatment Product Solution and Service
3.5 Date of Enter into Thyroid Cancer Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Thyroid Cancer Treatment Historic Market Size by Type (2015-2020)
4.2 Global Thyroid Cancer Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Thyroid Cancer Treatment Market Size by Application (2015-2020)
5.2 Global Thyroid Cancer Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Thyroid Cancer Treatment Market Size (2015-2020)
6.2 Thyroid Cancer Treatment Key Players in North America (2019-2020)
6.3 North America Thyroid Cancer Treatment Market Size by Type (2015-2020)
6.4 North America Thyroid Cancer Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Thyroid Cancer Treatment Market Size (2015-2020)
7.2 Thyroid Cancer Treatment Key Players in Europe (2019-2020)
7.3 Europe Thyroid Cancer Treatment Market Size by Type (2015-2020)
7.4 Europe Thyroid Cancer Treatment Market Size by Application (2015-2020)

8 China
8.1 China Thyroid Cancer Treatment Market Size (2015-2020)
8.2 Thyroid Cancer Treatment Key Players in China (2019-2020)
8.3 China Thyroid Cancer Treatment Market Size by Type (2015-2020)
8.4 China Thyroid Cancer Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Thyroid Cancer Treatment Market Size (2015-2020)
9.2 Thyroid Cancer Treatment Key Players in Japan (2019-2020)
9.3 Japan Thyroid Cancer Treatment Market Size by Type (2015-2020)
9.4 Japan Thyroid Cancer Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Thyroid Cancer Treatment Market Size (2015-2020)
10.2 Thyroid Cancer Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Thyroid Cancer Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Thyroid Cancer Treatment Market Size by Application (2015-2020)

11 India
11.1 India Thyroid Cancer Treatment Market Size (2015-2020)
11.2 Thyroid Cancer Treatment Key Players in India (2019-2020)
11.3 India Thyroid Cancer Treatment Market Size by Type (2015-2020)
11.4 India Thyroid Cancer Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Thyroid Cancer Treatment Market Size (2015-2020)
12.2 Thyroid Cancer Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Thyroid Cancer Treatment Market Size by Type (2015-2020)
12.4 Central & South America Thyroid Cancer Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Baxter
13.1.1 Baxter Company Details
13.1.2 Baxter Business Overview
13.1.3 Baxter Thyroid Cancer Treatment Introduction
13.1.4 Baxter Revenue in Thyroid Cancer Treatment Business (2015-2020))
13.1.5 Baxter Recent Development
13.2 Mylan
13.2.1 Mylan Company Details
13.2.2 Mylan Business Overview
13.2.3 Mylan Thyroid Cancer Treatment Introduction
13.2.4 Mylan Revenue in Thyroid Cancer Treatment Business (2015-2020)
13.2.5 Mylan Recent Development
13.3 Alara
13.3.1 Alara Company Details
13.3.2 Alara Business Overview
13.3.3 Alara Thyroid Cancer Treatment Introduction
13.3.4 Alara Revenue in Thyroid Cancer Treatment Business (2015-2020)
13.3.5 Alara Recent Development
13.4 Bristol Myers
13.4.1 Bristol Myers Company Details
13.4.2 Bristol Myers Business Overview
13.4.3 Bristol Myers Thyroid Cancer Treatment Introduction
13.4.4 Bristol Myers Revenue in Thyroid Cancer Treatment Business (2015-2020)
13.4.5 Bristol Myers Recent Development
13.5 Abbott
13.5.1 Abbott Company Details
13.5.2 Abbott Business Overview
13.5.3 Abbott Thyroid Cancer Treatment Introduction
13.5.4 Abbott Revenue in Thyroid Cancer Treatment Business (2015-2020)
13.5.5 Abbott Recent Development
13.6 Teva
13.6.1 Teva Company Details
13.6.2 Teva Business Overview
13.6.3 Teva Thyroid Cancer Treatment Introduction
13.6.4 Teva Revenue in Thyroid Cancer Treatment Business (2015-2020)
13.6.5 Teva Recent Development
13.7 App pharmaceuticals
13.7.1 App pharmaceuticals Company Details
13.7.2 App pharmaceuticals Business Overview
13.7.3 App pharmaceuticals Thyroid Cancer Treatment Introduction
13.7.4 App pharmaceuticals Revenue in Thyroid Cancer Treatment Business (2015-2020)
13.7.5 App pharmaceuticals Recent Development
13.8 Jerome Stevens
13.8.1 Jerome Stevens Company Details
13.8.2 Jerome Stevens Business Overview
13.8.3 Jerome Stevens Thyroid Cancer Treatment Introduction
13.8.4 Jerome Stevens Revenue in Thyroid Cancer Treatment Business (2015-2020)
13.8.5 Jerome Stevens Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Thyroid Cancer Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Thyroid Cancer Treatment Revenue
Table 3. Ranking of Global Top Thyroid Cancer Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Thyroid Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Iodine Therapy
Table 7. Key Players of External Radiotherapy
Table 8. Key Players of Thyroxin Treatment
Table 9. Key Players of Chemotherapy
Table 10. Key Players of Drugs
Table 11. Global Thyroid Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Thyroid Cancer Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Thyroid Cancer Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Thyroid Cancer Treatment Market Share by Regions (2015-2020)
Table 15. Global Thyroid Cancer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Thyroid Cancer Treatment Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Thyroid Cancer Treatment Market Growth Strategy
Table 21. Main Points Interviewed from Key Thyroid Cancer Treatment Players
Table 22. Global Thyroid Cancer Treatment Revenue by Players (2015-2020) (Million US$)
Table 23. Global Thyroid Cancer Treatment Market Share by Players (2015-2020)
Table 24. Global Top Thyroid Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thyroid Cancer Treatment as of 2019)
Table 25. Global Thyroid Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Thyroid Cancer Treatment Product Solution and Service
Table 28. Date of Enter into Thyroid Cancer Treatment Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Thyroid Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 31. Global Thyroid Cancer Treatment Market Size Share by Type (2015-2020)
Table 32. Global Thyroid Cancer Treatment Revenue Market Share by Type (2021-2026)
Table 33. Global Thyroid Cancer Treatment Market Size Share by Application (2015-2020)
Table 34. Global Thyroid Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 35. Global Thyroid Cancer Treatment Market Size Share by Application (2021-2026)
Table 36. North America Key Players Thyroid Cancer Treatment Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Thyroid Cancer Treatment Market Share (2019-2020)
Table 38. North America Thyroid Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 39. North America Thyroid Cancer Treatment Market Share by Type (2015-2020)
Table 40. North America Thyroid Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 41. North America Thyroid Cancer Treatment Market Share by Application (2015-2020)
Table 42. Europe Key Players Thyroid Cancer Treatment Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Thyroid Cancer Treatment Market Share (2019-2020)
Table 44. Europe Thyroid Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Thyroid Cancer Treatment Market Share by Type (2015-2020)
Table 46. Europe Thyroid Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Thyroid Cancer Treatment Market Share by Application (2015-2020)
Table 48. China Key Players Thyroid Cancer Treatment Revenue (2019-2020) (Million US$)
Table 49. China Key Players Thyroid Cancer Treatment Market Share (2019-2020)
Table 50. China Thyroid Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 51. China Thyroid Cancer Treatment Market Share by Type (2015-2020)
Table 52. China Thyroid Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 53. China Thyroid Cancer Treatment Market Share by Application (2015-2020)
Table 54. Japan Key Players Thyroid Cancer Treatment Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Thyroid Cancer Treatment Market Share (2019-2020)
Table 56. Japan Thyroid Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Thyroid Cancer Treatment Market Share by Type (2015-2020)
Table 58. Japan Thyroid Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Thyroid Cancer Treatment Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Thyroid Cancer Treatment Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Thyroid Cancer Treatment Market Share (2019-2020)
Table 62. Southeast Asia Thyroid Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Thyroid Cancer Treatment Market Share by Type (2015-2020)
Table 64. Southeast Asia Thyroid Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Thyroid Cancer Treatment Market Share by Application (2015-2020)
Table 66. India Key Players Thyroid Cancer Treatment Revenue (2019-2020) (Million US$)
Table 67. India Key Players Thyroid Cancer Treatment Market Share (2019-2020)
Table 68. India Thyroid Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 69. India Thyroid Cancer Treatment Market Share by Type (2015-2020)
Table 70. India Thyroid Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 71. India Thyroid Cancer Treatment Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Thyroid Cancer Treatment Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Thyroid Cancer Treatment Market Share (2019-2020)
Table 74. Central & South America Thyroid Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Thyroid Cancer Treatment Market Share by Type (2015-2020)
Table 76. Central & South America Thyroid Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Thyroid Cancer Treatment Market Share by Application (2015-2020)
Table 78. Baxter Company Details
Table 79. Baxter Business Overview
Table 80. Baxter Product
Table 81. Baxter Revenue in Thyroid Cancer Treatment Business (2015-2020) (Million US$)
Table 82. Baxter Recent Development
Table 83. Mylan Company Details
Table 84. Mylan Business Overview
Table 85. Mylan Product
Table 86. Mylan Revenue in Thyroid Cancer Treatment Business (2015-2020) (Million US$)
Table 87. Mylan Recent Development
Table 88. Alara Company Details
Table 89. Alara Business Overview
Table 90. Alara Product
Table 91. Alara Revenue in Thyroid Cancer Treatment Business (2015-2020) (Million US$)
Table 92. Alara Recent Development
Table 93. Bristol Myers Company Details
Table 94. Bristol Myers Business Overview
Table 95. Bristol Myers Product
Table 96. Bristol Myers Revenue in Thyroid Cancer Treatment Business (2015-2020) (Million US$)
Table 97. Bristol Myers Recent Development
Table 98. Abbott Company Details
Table 99. Abbott Business Overview
Table 100. Abbott Product
Table 101. Abbott Revenue in Thyroid Cancer Treatment Business (2015-2020) (Million US$)
Table 102. Abbott Recent Development
Table 103. Teva Company Details
Table 104. Teva Business Overview
Table 105. Teva Product
Table 106. Teva Revenue in Thyroid Cancer Treatment Business (2015-2020) (Million US$)
Table 107. Teva Recent Development
Table 108. App pharmaceuticals Company Details
Table 109. App pharmaceuticals Business Overview
Table 110. App pharmaceuticals Product
Table 111. App pharmaceuticals Revenue in Thyroid Cancer Treatment Business (2015-2020) (Million US$)
Table 112. App pharmaceuticals Recent Development
Table 113. Jerome Stevens Business Overview
Table 114. Jerome Stevens Product
Table 115. Jerome Stevens Company Details
Table 116. Jerome Stevens Revenue in Thyroid Cancer Treatment Business (2015-2020) (Million US$)
Table 117. Jerome Stevens Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Thyroid Cancer Treatment Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Iodine Therapy Features
Figure 4. External Radiotherapy Features
Figure 5. Thyroxin Treatment Features
Figure 6. Chemotherapy Features
Figure 7. Drugs Features
Figure 8. Global Thyroid Cancer Treatment Market Share by Application: 2020 VS 2026
Figure 9. Hospitals Case Studies
Figure 10. Oncology centers Case Studies
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Thyroid Cancer Treatment Report Years Considered
Figure 14. Global Thyroid Cancer Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Thyroid Cancer Treatment Market Share by Regions: 2020 VS 2026
Figure 16. Global Thyroid Cancer Treatment Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Thyroid Cancer Treatment Market Share by Players in 2019
Figure 19. Global Top Thyroid Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thyroid Cancer Treatment as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Thyroid Cancer Treatment Revenue in 2019
Figure 21. North America Thyroid Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Thyroid Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Thyroid Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Thyroid Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Thyroid Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Thyroid Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Thyroid Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed

以下、関連資料のご紹介

甲状腺障害治療の世界市場（～2026年）

Global Thyroid Gland Disorder Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04853 2020年11月20日 93Pages
当調査資料は甲状腺障害治療のグローバル市場について調査・分析したレポートです。種類別（甲状腺機能亢進症、甲状腺機能低下症、その他）市場規模、用途別（男性、女性）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...

甲状腺未分化癌治療薬の世界市場（～2026年）

Global Anaplastic Thyroid Cancer Drug Market Insights and Forecast to 2026
MRC2-11QY02430 2020年11月20日 113Pages
当調査資料は甲状腺未分化癌治療薬のグローバル市場について調査・分析したレポートです。種類別（CLM-94、クロリブリン、エファタゾン、GLONC-2、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...

下咽頭がん治療の世界市場（～2026年）

Global Hypopharyngeal Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12289 2020年11月25日 92Pages
当調査資料は下咽頭がん治療のグローバル市場について調査・分析したレポートです。種類別（ガネテスピブ、PGV-001、ニモツズマブ、CDX-3379、その他）市場規模、用途別（外来患者、入院患者）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...

転移性膵臓がん治療の世界市場（～2026年）

Global Metastatic Pancreatic Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12667 2020年11月25日 99Pages
当調査資料は転移性膵臓がん治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、標的療法、その他）市場規模、用途別（外分泌、内分泌）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台...

非血液がん治療の世界市場（～2026年）

Global Non-Hematological Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04000 2020年11月20日 97Pages
当調査資料は非血液がん治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、手術、放射線療法、その他）市場規模、用途別（病院、腫瘍治療センター、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...

前立腺がん治療の世界市場（～2026年）

Global Prostate Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04391 2020年11月20日 91Pages
当調査資料は前立腺がん治療のグローバル市場について調査・分析したレポートです。種類別（生物学的療法、化学療法）市場規模、用途別（病院、研究機関、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア...

小細胞肺がん治療の世界市場（～2026年）

Global Small Cell Lung Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04652 2020年11月20日 99Pages
当調査資料は小細胞肺がん治療のグローバル市場について調査・分析したレポートです。種類別（小細胞がん、混合型小細胞がん）市場規模、用途別（手術、放射線療法、化学療法）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オース...

転移性がん治療の世界市場（～2026年）

Global Metastatic Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12665 2020年11月25日 91Pages
当調査資料は転移性がん治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、生物学的標的療法、乳腺手術、ホルモン療法）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...

甲状腺機能検査の世界市場（～2026年）

Global Thyroid Functioning Tests Market Size, Status and Forecast 2020-2026
MRC2-11QY04852 2020年11月20日 90Pages
当調査資料は甲状腺機能検査のグローバル市場について調査・分析したレポートです。種類別（TSHテスト、FT3テスト、FT4テスト）市場規模、用途別（病院、診断センター、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...

口腔がん治療の世界市場（～2026年）

Global Oral Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04078 2020年11月20日 98Pages
当調査資料は口腔がん治療のグローバル市場について調査・分析したレポートです。種類別（扁平上皮がん、疣贅がん、小唾液腺がん、リンパ腫）市場規模、用途別（病院・診療所、研究機関、学術機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、...

甲状腺障害治療の世界市場（～2026年） Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect major…
非血液がん治療の世界市場（～2026年） Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient. North America has the huge number of population suffering fr…
甲状腺未分化癌治療薬の世界市場（～2026年） Market Analysis and Insights: Global Anaplastic Thyroid Cancer Drug Market The global Anaplastic Thyroid Cancer Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anaplastic Thyroid Cancer Drug Scope and Market Size …
転移性がん治療の世界市場（～2026年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
小細胞肺がん治療の世界市場（～2026年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Small Cell Lung Cancer Treatment Scope and Market…